RxDoctor Payments DataLook up a doctor →

Scott Boyken, MD

Sports Medicine · Trussville, ALNPI 1245551878

Payments from drug & device makers

$16,423in general payments, 2019–2025

Across 1,119 payments — averaging $14.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Pfizer$2K
  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • AstraZeneca$1K
  • plus $6K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk301$3,279
Pfizer107$1,701
AbbVie(2 entities)114$1,442
Lilly USA, LLC95$1,352
Amgen(2 entities)78$1,235
AstraZeneca70$1,152
GSK55$1,079
Takeda Pharmaceuticals U.S.A., Inc.40$756
Amarin Pharma, Inc.39$619
Boehringer Ingelheim24$383
Sanofi-aventis U.S. LLC19$310
Teva Pharmaceuticals USA, Inc.19$256
Johnson & Johnson(2 entities)15$241
Corium, LLC10$206
Otsuka America Pharmaceutical, Inc.9$196
Dexcom, Inc.11$191
Astellas Pharma US Inc10$187
Sumitomo Pharma America, Inc.9$171
Ironwood Pharmaceuticals, Inc10$162
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$156
Bayer8$150
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$133
Esperion Therapeutics, Inc.7$116
Axsome Therapeutics, Inc.4$93
Merck6$92
Kowa Pharmaceuticals America, Inc.7$90
Exact Sciences4$64
Biohaven Pharmaceutical Holding Company Ltd.3$59
Bristol Myers Squibb3$57
Biohaven Pharmaceuticals, Inc.3$47
Phathom Pharmaceuticals, Inc.2$43
Medicomp Inc1$40
UCB, Inc.1$37
Shield Therapeutics Inc2$35
Paratek Pharmaceuticals, Inc.2$29
Genentech USA, Inc.2$28
Axonics, Inc.1$24
Antares Pharma, Inc.1$22
Upsher-smith Laboratories LLC1$20
Abbott1$19
Tris Pharma Inc1$18
Ortho Dermatologics, A Division Of Bausch Health US, LLC1$18
IBSA Pharma Inc.1$18
Nestle Healthcare Nutrition Inc.1$16
Boston Scientific1$16
Medtronic1$16
Currax Pharmaceuticals LLC1$15
Xeris Pharmaceuticals, Inc.1$14
Idorsia Pharmaceuticals US Inc1$14
Hikma Pharmaceuticals USA1$12

How this compares

$16,423 in reported general payments places this provider in the 70th percentile of 108 sports medicine providers in Alabama.

See all sports medicine providers in Alabama →

Medicare billing

Part B allowed, 2024
$125,290
Medicare patients
228
Services billed
5,181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Trussville

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →